Purpose As advances in research have made a growing number of genetic tests available,
clinicians will increasingly be faced with making decisions about when offering genetic …

Objective: For women at high risk of developing hereditary breast and/or ovarian cancer the
process of undergoing genetic testing is anxiety provoking and stressful, entailing difficult …

BACKGROUND: Few studies have examined how patients understand and use genomic
test results when deciding about treatment. This study examined how women receive and …

We investigated estimated offspring risk among people with epilepsy and factors important
in the family‐planning process. Data were collected for 88 participants using a questionnaire …

Background Women who are notified they carry a BRCA1/2 mutation are presented with
surgical options to reduce their risk of breast and ovarian cancer, including risk-reducing …

The purpose of this study was to investigate prevention decision making among women at
high risk for breast cancer, including patient preferences for preventive interventions, patient …

The obligations of researchers to disclose clinically and/or personally significant individual
research results are highly debated, but few empirical studies have addressed this topic. We …

Genetic screening for BRCA1 and BRCA2 gives women the opportunity for early detection,
surveillance, and intervention. One key feature of genetic testing and counseling is the …

Advances in the genetic basis of kidney disease may mean that genetic testing is
increasingly important in reducing disease morbidity and mortality among patients …

Hereditary breast and ovarian cancer syndrome (HBOC) is responsible for most hereditary
breast and ovarian cancers. As an inheritable genetic disorder, parental carrier status …